QC
Quantessence Capital LLC
13F filer · CIK 0002009590Reported Aug 14, 2026
Net buyer this quarter
13F portfolio value$34MU.S. long equity reported on 13F
Positions7367 new · 58 closed
Net flow last quarter+$9.53MBuys minus sells
Top 10 positions weight27.8%Concentration
Holdings
13F · last 4 quarters freeScroll for earlier quarters
| Company | Value | % of portfolio | % of company | POSITION CHANGE qoq % | First reported |
|---|---|---|---|---|---|
| Q2 2026Reported Aug 14, 202673 positions | |||||
| $1.02M | 3.00% | 0.00% | New | Q2 2026 | |
| $1.01M | 2.96% | 0.00% | Not reported | Q1 2025 | |
| $987K | 2.90% | 0.00% | Not reported | Q4 2024 | |
| $972K | 2.86% | 0.00% | Not reported | Q4 2024 | |
| $965K | 2.84% | 0.00% | Not reported | Q4 2024 | |
| $933K | 2.75% | 0.01% | Not reported | Q3 2025 | |
| $929K | 2.74% | 0.00% | Not reported | Q1 2025 | |
| $915K | 2.69% | 0.00% | New | Q2 2026 | |
| $879K | 2.59% | 0.00% | New | Q2 2026 | |
| $841K | 2.48% | 0.00% | -25.0% | Q3 2025 | |
| $803K | 2.36% | 0.00% | New | Q2 2026 | |
| $772K | 2.27% | 0.00% | New | Q2 2026 | |
| $711K | 2.09% | 0.00% | Not reported | Q3 2025 | |
| $674K | 1.98% | 0.00% | Not reported | Q4 2024 | |
| $668K | 1.97% | 0.00% | Not reported | Q4 2024 | |
| $650K | 1.91% | 0.00% | New | Q2 2026 | |
| $608K | 1.79% | 0.00% | New | Q2 2026 | |
| $594K | 1.75% | 0.00% | New | Q2 2026 | |
| TBLDTopBuild Corp | $585K | 1.72% | 0.01% | Not reported | Q4 2024 |
| $584K | 1.72% | 0.00% | -43.7% | Q4 2024 | |
| $572K | 1.68% | 0.00% | Not reported | Q4 2024 | |
| $570K | 1.68% | 0.00% | Not reported | Q4 2024 | |
| $520K | 1.53% | 0.00% | Not reported | Q4 2024 | |
| $494K | 1.46% | 0.00% | New | Q2 2026 | |
| $484K | 1.42% | 0.00% | Not reported | Q1 2025 | |
| $458K | 1.35% | 0.00% | New | Q2 2026 | |
| $453K | 1.33% | 0.00% | -45.9% | Q4 2024 | |
| $447K | 1.32% | 0.00% | New | Q2 2026 | |
| $447K | 1.32% | 0.00% | New | Q2 2026 | |
| $435K | 1.28% | 0.00% | Not reported | Q4 2024 | |
| $429K | 1.26% | 0.00% | Not reported | Q4 2024 | |
| $428K | 1.26% | 0.00% | Not reported | Q4 2024 | |
| $417K | 1.23% | 0.00% | New | Q2 2026 | |
| $398K | 1.17% | 0.00% | New | Q2 2026 | |
| $390K | 1.15% | 0.00% | New | Q2 2026 | |
| $384K | 1.13% | 0.00% | New | Q2 2026 | |
| $363K | 1.07% | 0.00% | Not reported | Q2 2025 | |
| $362K | 1.07% | Not reported | Not reported | Q2 2025 | |
| $359K | 1.06% | 0.00% | Not reported | Q1 2025 | |
| $353K | 1.04% | 0.00% | New | Q2 2026 | |
| $344K | 1.01% | 0.00% | New | Q2 2026 | |
| $339K | 1.00% | 0.00% | New | Q2 2026 | |
| $327K | 0.96% | Not reported | New | Q2 2026 | |
| $319K | 0.94% | 0.00% | New | Q2 2026 | |
| $318K | 0.94% | 0.00% | Not reported | Q4 2024 | |
| $315K | 0.93% | Not reported | -46.8% | Q1 2026 | |
| $310K | 0.91% | 0.00% | Not reported | Q4 2024 | |
| $276K | 0.81% | 0.00% | -29.5% | Q1 2025 | |
| $276K | 0.81% | 0.00% | Not reported | Q4 2024 | |
| $273K | 0.80% | 0.00% | New | Q2 2026 | |
| Q1 2026Reported May 15, 202664 positions | |||||
| $727K | 3.54% | 0.00% | New | Q1 2026 | |
| $667K | 3.25% | Not reported | New | Q1 2026 | |
| $607K | 2.96% | 0.00% | Not reported | Q3 2025 | |
| $605K | 2.94% | 0.00% | Not reported | Q2 2025 | |
| $591K | 2.88% | 0.00% | New | Q1 2026 | |
| $590K | 2.88% | 0.00% | Not reported | Q1 2025 | |
| $586K | 2.86% | 0.00% | Not reported | Q4 2024 | |
| $571K | 2.78% | 0.00% | Not reported | Q4 2024 | |
| $556K | 2.71% | 0.00% | Not reported | Q1 2025 | |
| $553K | 2.69% | 0.00% | Not reported | Q4 2024 | |
| $553K | 2.69% | 0.00% | Not reported | Q1 2025 | |
| $536K | 2.61% | 0.00% | New | Q1 2026 | |
| $531K | 2.58% | 0.00% | New | Q1 2026 | |
| $513K | 2.50% | 0.00% | Not reported | Q3 2025 | |
| $511K | 2.49% | 0.00% | Not reported | Q4 2024 | |
| $502K | 2.44% | 0.00% | New | Q1 2026 | |
| $462K | 2.25% | 0.00% | New | Q1 2026 | |
| $456K | 2.22% | 0.00% | Not reported | Q3 2025 | |
| $455K | 2.21% | 0.00% | Not reported | Q1 2025 | |
| $444K | 2.16% | 0.00% | Not reported | Q4 2024 | |
| $438K | 2.13% | 0.00% | Not reported | Q4 2024 | |
| $417K | 2.03% | 0.00% | New | Q1 2026 | |
| $369K | 1.80% | 0.00% | Not reported | Q4 2024 | |
| $362K | 1.76% | 0.00% | Not reported | Q1 2025 | |
| $360K | 1.75% | 0.00% | New | Q1 2026 | |
| $355K | 1.73% | 0.00% | New | Q1 2026 | |
| $348K | 1.70% | Not reported | New | Q1 2026 | |
| $328K | 1.60% | 0.00% | New | Q1 2026 | |
| $326K | 1.59% | 0.00% | New | Q1 2026 | |
| $314K | 1.53% | 0.03% | New | Q1 2026 | |
| $310K | 1.51% | 0.00% | Not reported | Q4 2024 | |
| $309K | 1.51% | 0.00% | Not reported | Q1 2025 | |
| $309K | 1.51% | 0.00% | Not reported | Q1 2025 | |
| $304K | 1.48% | 0.00% | New | Q1 2026 | |
| $299K | 1.46% | 0.00% | Not reported | Q2 2025 | |
| $286K | 1.39% | 0.00% | New | Q1 2026 | |
| $284K | 1.38% | Not reported | New | Q1 2026 | |
| $277K | 1.35% | 0.00% | New | Q1 2026 | |
| $255K | 1.24% | 0.00% | Not reported | Q4 2024 | |
| $254K | 1.24% | 0.00% | Not reported | Q3 2025 | |
| $241K | 1.17% | 0.00% | Not reported | Q4 2024 | |
| $237K | 1.15% | 0.00% | New | Q1 2026 | |
| $229K | 1.12% | Not reported | Not reported | Q2 2025 | |
| $220K | 1.07% | 0.00% | Not reported | Q2 2025 | |
| $220K | 1.07% | 0.00% | Not reported | Q4 2024 | |
| $216K | 1.05% | 0.00% | Not reported | Q1 2025 | |
| $206K | 1.01% | 0.00% | Not reported | Q4 2024 | |
| APAPLSApellis Pharmaceuticals, Inc. | $206K | 1.00% | 0.00% | New | Q1 2026 |
| $204K | 0.99% | 0.00% | Not reported | Q4 2024 | |
| $201K | 0.98% | 0.00% | Not reported | Q4 2024 | |
| Q4 2025Reported Feb 17, 202614 positions | |||||
| $1.04M | 12.06% | 0.00% | New | Q4 2025 | |
| $1.02M | 11.76% | 0.00% | Not reported | Q4 2024 | |
| $1M | 11.60% | 0.00% | New | Q4 2025 | |
| $986K | 11.41% | 0.00% | Not reported | Q4 2024 | |
| $933K | 10.79% | 0.00% | Not reported | Q1 2025 | |
| $712K | 8.23% | 0.00% | New | Q4 2025 | |
| $639K | 7.40% | 0.00% | New | Q4 2025 | |
| $260K | 3.00% | Not reported | Not reported | Q2 2025 | |
| $253K | 2.92% | 345600.00% | Not reported | Q4 2024 | |
| $103K | 1.19% | 0.01% | New | Q4 2025 | |
| $96.9K | 1.12% | 0.01% | Not reported | Q1 2025 | |
| $78K | 0.90% | 0.00% | Not reported | Q4 2024 | |
| $77.9K | 0.90% | Not reported | New | Q4 2025 | |
| $49.9K | 0.58% | 0.01% | New | Q4 2025 | |
| Q3 2025Reported Nov 14, 2025168 positions | |||||
| WWNSWNS (Holdings) Limited | $25M | 7.90% | 0.76% | New | Q3 2025 |
| VPVRNAVerona Pharma plc | $11.8M | 3.72% | 0.02% | New | Q3 2025 |
| $9.07M | 2.87% | Not reported | -27.9% | Q4 2024 | |
| $8.11M | 2.57% | Not reported | Not reported | Q4 2024 | |
| $7.24M | 2.29% | 0.01% | New | Q3 2025 | |
| $7.21M | 2.28% | 0.00% | +202.2% | Q2 2025 | |
| $6.45M | 2.04% | 0.02% | New | Q3 2025 | |
| AALEAllete Inc | $6.24M | 1.97% | 0.16% | New | Q3 2025 |
| $5.92M | 1.87% | 0.01% | Not reported | Q1 2025 | |
| $5.89M | 1.86% | 0.00% | Not reported | Q4 2024 | |
| $5.55M | 1.76% | 0.00% | New | Q3 2025 | |
| $5.3M | 1.68% | 0.00% | Not reported | Q4 2024 | |
| $5.19M | 1.64% | 0.01% | New | Q3 2025 | |
| $5.06M | 1.60% | 0.04% | New | Q3 2025 | |
| $4.37M | 1.38% | 0.00% | New | Q3 2025 | |
| $4.05M | 1.28% | 0.01% | -62.8% | Q2 2025 | |
| $4.01M | 1.27% | 0.01% | Not reported | Q4 2024 | |
| $4M | 1.27% | 0.01% | Not reported | Q1 2025 | |
| $3.98M | 1.26% | 0.00% | -3.5% | Q4 2024 | |
| $3.92M | 1.24% | 0.00% | Not reported | Q1 2025 | |
| $3.89M | 1.23% | 0.00% | New | Q3 2025 | |
| $3.8M | 1.20% | 0.00% | Not reported | Q1 2025 | |
| ZZIMVZimvie Inc. | $3.79M | 1.20% | 0.71% | New | Q3 2025 |
| $3.74M | 1.18% | 0.01% | New | Q3 2025 | |
| $3.57M | 1.13% | 0.01% | New | Q3 2025 | |
| $3.55M | 1.12% | 0.01% | New | Q3 2025 | |
| $3.35M | 1.06% | 0.00% | New | Q3 2025 | |
| $3.34M | 1.06% | Not reported | New | Q3 2025 | |
| $3.31M | 1.05% | 0.01% | Not reported | Q4 2024 | |
| $3.2M | 1.01% | 0.01% | Not reported | Q1 2025 | |
| $3.18M | 1.01% | 0.00% | New | Q3 2025 | |
| HHBIHanesbrands Inc. | $3.16M | 1.00% | 0.14% | Not reported | Q1 2025 |
| $3.08M | 0.98% | 0.00% | New | Q3 2025 | |
| $3.05M | 0.97% | 0.01% | +90.0% | Q4 2024 | |
| $3.05M | 0.96% | 0.00% | Not reported | Q1 2025 | |
| $3.02M | 0.95% | Not reported | New | Q3 2025 | |
| $2.94M | 0.93% | 0.01% | New | Q3 2025 | |
| $2.91M | 0.92% | 0.01% | New | Q3 2025 | |
| $2.9M | 0.92% | 0.01% | New | Q3 2025 | |
| $2.89M | 0.92% | 0.01% | New | Q3 2025 | |
| $2.84M | 0.90% | 0.02% | New | Q3 2025 | |
| PHPHLTPerformant Healthcare, Inc. | $2.65M | 0.84% | Not reported | New | Q3 2025 |
| $2.54M | 0.80% | 0.01% | New | Q3 2025 | |
| $2.31M | 0.73% | 0.14% | Not reported | Q1 2025 | |
| $2.27M | 0.72% | 0.00% | New | Q3 2025 | |
| $2.05M | 0.65% | 0.00% | Not reported | Q1 2025 | |
| $1.94M | 0.61% | 0.01% | New | Q3 2025 | |
| $1.85M | 0.59% | 0.01% | +48.4% | Q4 2024 | |
| $1.71M | 0.54% | 0.00% | Not reported | Q4 2024 | |
| $1.57M | 0.50% | 0.07% | Not reported | Q1 2025 | |
Premium opens every quarter this fund has filed